InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,112.86
(
1.28%
)
US TECH 100
17,288.80
(
1.83%
)
Dow Jones
38,320.26
(
0.62%
)
Brent Oil
88.27
(
0.13%
)
Bitcoin
64,010.86
(
-0.73%
)
Post# of 1109
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

BelizeBeachTrader

Send PM Follow Ignore
Followers 5
Posts 213
Boards Moderated 0
Alias Born 08/19/2013

BelizeBeachTrader

Re: XxJamesAxX post# 47

Friday, 12/30/2016 2:21:29 PM

Friday, December 30, 2016 2:21:29 PM

Post# of 1109
Corporate presentation page 18. Pivotal efficiency Study completion Q1 2017.
Safety Study continues through Q2 2018.

http://files.shareholder.com/downloads/AMDA-31G0T0/3469242437x0x893779/12EE7D61-3AA4-4766-B8FC-0DABAE900EB7/ZSAN_Corporate_Presentation_May_2016.pdf


FDA site, estimated study completion date Jan. 2017

https://clinicaltrials.gov/ct2/show/NCT02745392?term=zosano&rank=3

We should see the Pivotal efficiency data sometime in Q1 2017.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up